PEPFAR's annual planning process is done either at the country (COP) or regional level (ROP).
PEPFAR's programs are implemented through implementing partners who apply for funding based on PEPFAR's published Requests for Applications.
Since 2010, PEPFAR COPs have grouped implementing partners according to an organizational type. We have retroactively applied these classifications to earlier years in the database as well.
Also called "Strategic Areas", these are general areas of HIV programming. Each program area has several corresponding budget codes.
Specific areas of HIV programming. Budget Codes are the lowest level of spending data available.
Expenditure Program Areas track general areas of PEPFAR expenditure.
Expenditure Sub-Program Areas track more specific PEPFAR expenditures.
Object classes provide highly specific ways that implementing partners are spending PEPFAR funds on programming.
Cross-cutting attributions are areas of PEPFAR programming that contribute across several program areas. They contain limited indicative information related to aspects such as human resources, health infrastructure, or key populations programming. However, they represent only a small proportion of the total funds that PEPFAR allocates through the COP process. Additionally, they have changed significantly over the years. As such, analysis and interpretation of these data should be approached carefully. Learn more
Beneficiary Expenditure data identify how PEPFAR programming is targeted at reaching different populations.
Sub-Beneficiary Expenditure data highlight more specific populations targeted for HIV prevention and treatment interventions.
PEPFAR sets targets using the Monitoring, Evaluation, and Reporting (MER) System - documentation for which can be found on PEPFAR's website at https://www.pepfar.gov/reports/guidance/. As with most data on this website, the targets here have been extracted from the COP documents. Targets are for the fiscal year following each COP year, such that selecting 2016 will access targets for FY2017. This feature is currently experimental and should be used for exploratory purposes only at present.
Years of mechanism: 2012 2013 2014 2015
Along with supporting treatment services, PEPFAR/Vietnam is working closely with the Government of Vietnam (GVN) in the transition process. Commodities transition appears to be the most challenging component, especially ARVs, not only because of its financial burden to GVN but also of the whole pharmaceutical, logistics and financing structures are not ready yet. Vietnam has very limited pharmaceutical market that failed can provide best international price and doesnt have a simple process to procure internationally neither. As a result, ARVs procured in country are between 3-17 times higher than PEPFAR procured ARVs and 2-3 times higher than Thailand, its neighbor country. This South to South exchange will support a study tour for relevant GVN managers to Thailand to learn about Thai experience in ensuring non-interrupted ARV supply chain for HIV program. The study tour will focus on ARV local production, procurement, logistics and financing systems.
This is 2010 Partnership Framework money.
? Work closely with the Government of Vietnam to select potential manufacturers to produce methadone locally.? Recommend two best companies for production based on Good Manufacturing Practices assessment of manufacturing plants of companies selected. Provide recommendations for addressing GMP deficiencies.? Develop quality specifications for local production of methadone.? Establish and validate process control and QA/QC. Develop other necessary technical documents as required for licensing authorization.? Submit application to DAV for license to produce methadone in Vietnam, in accordance to the DAV requirements. Help the company to consolidate and respond queries from DAV as appropriate. Apply to DAV for registration number or marketing authorization.? Develop post-marketing surveillance program within the supply chain to ensure the quality of locally produced methadone.? Follow up and help the manufacturer to maintain GMP compliance and product quality throughout the supply and distribution chain.
